Lily Wong Lee Lee

Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study

Jong Wook Lee, Flore Sicre de Fontbrune, Lily Wong Lee Lee et al. · Blood · 2018 · 400 citations · Full text

Life Sciences, Immunology, Pharmacology +11

Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria

Régis Peffault de Latour, Alexander Röth, Austin Kulasekararaj et al. · New England Journal of Medicine · 2024 · 141 citations · Full text

Medicine, Hematology, Pharmacology +7

Phase 3 study of gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia

Jianxiang Wang, Bin Jiang, Ligen Liu et al. · Leukemia · 2024 · 14 citations · Full text

Medicine, Oncology, Pharmacology +12

Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors

Antonio M. Risitano, Austin Kulasekararaj, Phillip Scheinberg et al. · The Lancet Haematology · 2025 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7